A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage

OBJECTIVE: Studies show that phosphodiesterase-V (PDE-V) inhibition reduces cerebral vasospasm (CVS) and improves outcomes after experimental subarachnoid hemorrhage (SAH). This study was performed to investigate the safety and effect of sildenafil (an FDA-approved PDE-V inhibitor) on angiographic C...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Neurosurg
Main Authors: Washington, Chad W., Derdeyn, Colin P., Dhar, Rajat, Arias, Eric J., Chicoine, Michael R., Cross, DeWitte T., Dacey, Ralph G., Han, Byung Hee, Moran, Christopher J., Rich, Keith M., Vellimana, Ananth K., Zipfel, Gregory J.
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8157481/
https://ncbi.nlm.nih.gov/pubmed/26314998
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2015.2.JNS142752
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares